Praxis Precision Medicines, Inc.
PRAX
$48.09
-$0.69-1.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 3.62% | 8.03% | |||
| Gross Profit | -3.62% | -24.54% | |||
| SG&A Expenses | -6.18% | -7.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.79% | 4.63% | |||
| Operating Income | -1.79% | -16.84% | |||
| Income Before Tax | -2.64% | -18.09% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.64% | -18.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.64% | -18.09% | |||
| EBIT | -1.79% | -16.84% | |||
| EBITDA | -1.79% | -16.86% | |||
| EPS Basic | -0.64% | -12.06% | |||
| Normalized Basic EPS | 1.11% | -11.41% | |||
| EPS Diluted | -0.64% | -12.06% | |||
| Normalized Diluted EPS | 1.11% | -11.41% | |||
| Average Basic Shares Outstanding | 1.99% | 5.38% | |||
| Average Diluted Shares Outstanding | 1.99% | 5.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||